⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

COYA News

Coya Therapeutics, Inc. Common Stock

Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)